MET and cancer: We choose to study HGF/SF-Met signaling effects on cell motility since: 1) it is a well characterized signaling pathway in different aspects of cell motility; 2) the molecular tools to study this pathway are well established enabling to effectively inhibit Met signaling [26]; 3) The relevance of this signaling pathway to cancer and especially metastasis [27], [28].